ASPIRIN FOR LIFE
DEAD

Serial Number

90764540

Owner

PLx Pharma, Inc.

Attorney

Mary L. Grieco

Filing Date

Jun 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ASPIRIN FOR LIFE Trademark

Serial Number: 90764540

ASPIRIN FOR LIFE is a trademark filed by PLx Pharma, Inc. on June 9, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

PLx Pharma, Inc. (38 trademarks)

8285 El Rio, Suite 130
Houston, TX 77054

Entity Type: 03

Trademark Details

Filing Date

June 9, 2021

Registration Date

Not Registered

Published for Opposition

October 12, 2021

Goods & Services

Aspirin

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 10, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 10, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2022 EXRA
SOU EXTENSION 2 GRANTED
Nov 28, 2022 EX2G
SOU EXTENSION 2 FILED
Nov 28, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2022 EXRA
SOU EXTENSION 1 GRANTED
May 13, 2022 EX1G
SOU EXTENSION 1 FILED
May 13, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
May 13, 2022 EEXT
CORRECTED NOA E-MAILED
Feb 4, 2022 NOAC
NOTICE OF ALLOWANCE CORRECTION ENTERED
Feb 3, 2022 ICNA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 3, 2022 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 4, 2022 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 7, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 2, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 2, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 2, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 2, 2021 CNEA
ASSIGNED TO EXAMINER
Sep 1, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2021 NWOS
NEW APPLICATION ENTERED
Jun 12, 2021 NWAP